Psychedelics like psilocybin, LSD, and MDMA show promise for mental health, particularly in treating depression, PTSD, and anxiety. Research suggests they enhance neuroplasticity, promote emotional breakthroughs, and reduce symptoms by altering brain connectivity. Clinical trials indicate lasting benefits with guided therapy, though risks include bad trips, psychological distress, and regulatory challenges.